Search Results481 results found
Should you get both vaccinations? Yes, says an infectious disease doctor with the U.S. National Foundation for Infectious Diseases.
CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2023/24 U.S. Season - Jul 17, 2023
Since the COVID-19 pandemic, there has been a significant drop in influenza immunization rates and high levels of influenza-related illness, underscoring that flu is an ongoing threat.
CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics - Dec 12, 2022
2 During the COVID-19 pandemic, there have been over 95 million confirmed cases of the disease and over 1 million deaths in the U.S. 3 The Centers for Disease Control and Prevention (CDC) recommends COVID-19 vaccination for everyone ages six months and older in the U.S. for the prevention of COVID-19.
3 In an influenza-COVID-19 co-circulation scenario, the immunization rate with QIVc/aQIV would need to be at least 60 percent to prevent ICU bed saturation.
CSL Seqirus Shares Data Demonstrating the Potential for Influenza Vaccination to Reduce the Burden on Healthcare Resources
1 Additionally, enhanced vaccines are projected to further reduce the strain on hospitals and intensive care units by 10-15%, supporting bed availability during a potential COVID-19 endemic wave.
The COVID-19 pandemic and recently active flu season in the Southern Hemisphere attest to the burden high rates of respiratory infections, including influenza, can place on hospitals, which are the vanguard of a nation's health system," said Gregg Sylvester, MD, MPH, Chief Health Officer, CSL Seqirus.
CSL Seqirus has started shipping influenza vaccines to health care providers in the United States, helping them get prepared for the upcoming flu season.
CSL's product portfolio focuses on innovation in new products, improved products and manufacturing expertise thereby ensuring our continued growth.
CSL Seqirus to Present at 9th ESWI Conference on the Burden of Influenza and Impact of Vaccination on Public Health
Circulation and Seasonality of Epidemics of Influenza, RSV and Other Respiratory Viruses Before, During, and After the COVID-19 Pandemic: